Type 2 diabetes mellitus and prognosis in early stage breast cancer women

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1576-1580

  Kaplan, Muhammet Ali ^a   Pekkolay, Zafer ^a   Kucukoner, Mehmet ^a   Inal, Ali ^a   Urakci, Zuhat ^a   Ertugrul, Hamza ^a   Akdogan, Recai ^a   Firat, Ugur ^a   Yildiz, Ismail ^a   Isikdogan, Abdurrahman ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Comorbidity; Prognostic factor; Type 2 diabetes mellitus

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GLUCOSE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME;

BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84872803703     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0109-4     Document Type: Article

References (18)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
3. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61-9.
4. Papa V, Costantino A, Belfiore A. Insulin receptor what role in breast cancer? Trends Endocrinol Metab. 1997;8(8):306-12.
5. Van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol. 1988;134:101-8.
6. Belfiore A, Frittitta L, Costantino A, Frasca F, Pandini G, Sciacca L, et al. Insulin receptors in breast cancer. Ann NY Acad Sci. 1996;784:173-88.
7. Mathieu MC, Clark GM, Allred DC, Goldfine ID, Vigneri R. Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians. 1997;109:565-71.
8. Papa V, Belfiore A. Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest. 1996;19:324-33.
9. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754-64.
10. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121:856-62.
11. Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Rl Derr, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011;29(1):40-6.
12. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol. 2009;27:2170-6.
13. Fleming ST, Rastogi A, Dmitrienko A, Jhonson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37: 601-14.
14. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285: 885-92.
15. Van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120: 1986-92.
16. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care. 2005;43:132-40.
17. Unterburger P, Sinop A, Noder W, Berger MR, Fink M, Edler L, et al. Diabetes mellitus and breast cancer. A retrospective followup study. Onkologie. 1990;13(1):17-20.
18. Li CI, Daling JR, Tang MT, Malone KE. Relationship between diabetes and risk of second primary contralateral breast cancer. Breast Cancer Res Treat. 2011;125(2):545-51.